Ontology highlight
ABSTRACT:
SUBMITTER: Sillar JR
PROVIDER: S-EPMC6895902 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
Sillar Jonathan R JR Enjeti Anoop K AK
Cancers 20191026 11
Acute Myeloid Leukaemia is a devastating disease that continues to have a poor outcome for the majority of patients. In recent years, however, a number of drugs have received FDA approval, following on from successful clinical trial results. This parallels the characterization of the molecular landscape of Acute Myeloid Leukaemia (AML) over the last decade, which has led to the development of drugs targeting newly identified recurring mutations. In addition, basic biological research into the pa ...[more]